| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,442 | 10,715 | 10,170 | 12,826 | | Cost of Revenue | 13,897 | 8,184 | 7,752 | 9,970 | | | Gross Profit | 4,545 | 2,531 | 2,418 | 2,856 | | | Operating Expenses | | Research Development | 1,322 | 1,574 | 1,746 | 1,722 | | Selling General and Administrative | 2,004 | 2,166 | 2,149 | 1,026 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,219 | (1,209) | (1,477) | 108 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | 49 | 74 | 122 | | Earnings Before Interest And Taxes | 1,122 | (1,160) | (1,403) | 230 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,122 | (1,160) | (1,403) | 230 | | Income Tax Expense | 333 | (291) | (467) | (61) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,008 | (869) | (936) | 291 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,131 | (869) | (936) | 291 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,131 | ($869) | ($936) | $291 |
|
0.51% Nasdaq 
Income Statement
